MDC Holdings Inc. (NYSE:MDC) declared that it will release its fourth quarter 2014 earnings before trading session starts on January 28, 2015. The firm also declared that it will host a teleconference at 12:30 pm ET on the same day. On Thursday shares of MDC Holdings Inc. (NYSE:MDC) closed at $24.88. Company’s sales growth for last 5 years was 2.90% and EPS growth for next 5 years is recorded as -7.25%.
Barracuda Networks (NYSE:CUDA) CFO David Faugno sold 720 shares of the company’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $38.34, for a total transaction of $27,604.80. Following the transaction, the chief financial officer now directly owns 528,682 shares of the company’s stock, valued at approximately $20,269,667.88. Barracuda Networks, Inc. (NYSE:CUDA) in last trading activity decreased -8.42% to close at $33.73. Company weekly performance is -15.99% while its quarterly performance stands at 12.47%. Barracuda Networks, Inc. (NYSE:CUDA) is -24.03% away from its 52 week high.
Endocyte (NASDAQ:ECYT) has earned an average rating of “Buy” from the twelve brokerages that are presently covering the stock. On last trading day Endocyte, Inc. (NASDAQ:ECYT) decreased -5.36% to close at $5.30. Its volatility for the week is 6.40% while volatility for the month is 5.00%. ECYT’s sales growth for past 5 years was 164.60% and its EPS growth for past 5 years was 1.20%. Endocyte, Inc. (NASDAQ:ECYT) monthly performance is -12.25%.
Apple Inc. and Google Inc. (NASDAQ:GOOG) agreed to a $415 million settlement over claims they and other Silicon Valley companies conspired to avoid hiring one another’s employees, $90.5 million more than was in an accord that failed to win court approval four months ago. On Thursday shares of Google Inc (NASDAQ:GOOG) closed at $501.79. Company’s EPS growth for next 5 years is recorded as 14.60%.
Cord Blood Registry® (CBR®) and Cellular Dynamics International (NASDAQ: ICEL) (CDI) announced that they have entered into a research collaboration to reprogram newborn stem cells from both umbilical cord blood and umbilical cord tissue collected, processed and cryopreserved under CBR’s protocols into induced pluripotent stem cells (iPSCs) using CDI’s proprietary methods. On last trading day Cellular Dynamics International, Inc. (NASDAQ:ICEL) decreased -3.43% to close at $5.63. Its volatility for the week is 10.06% while volatility for the month is 9.90%. Cellular Dynamics International, Inc. (NASDAQ:ICEL) monthly performance is 6.83%.